Society guideline links: Management of bone metastases in solid tumors

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately:

●(See "Society guideline links: Cancer pain".)

●(See "Society guideline links: Multiple myeloma".)

●(See "Society guideline links: Diagnosis and management of prostate cancer".)

●(See "Society guideline links: Neoplastic epidural spinal cord compression".)

●(See "Society guideline links: Palliative care".)

International

●International Myeloma Working Group (IMWG): Recommendations for treatment of multiple myeloma-related bone disease (2021)

Canada

●Choosing Wisely Canada: Don't recommend more than a single fraction of palliative radiation for an uncomplicated painful bone metastasis (2021)

●American Society of Clinical Oncology (ASCO)-Cancer Care Ontario (CCO): Guideline on the role of bone-modifying agents in metastatic breast cancer, focused update (2017)

●CCO: Guideline on bone health and bone-targeted therapies for prostate cancer (2016)

United States

●American Society of Clinical Oncology (ASCO): Bone health and bone-targeted therapies for prostate cancer – Endorsement of a CCO guideline (2020)

●Musculoskeletal Tumor Society (MSTS), ASCO, and American Society for Radiation Oncology (ASTRO): Clinical practice guideline for the treatment of metastatic carcinoma and myeloma of the femur (2020)

●ASCO: Clinical practice guideline on the role of bone-modifying agents in multiple myeloma, update (2018)

●ASCO-Cancer Care Ontario (CCO): Guideline on the role of bone-modifying agents in metastatic breast cancer, focused update (2017)

●Choosing Wisely: Don't routinely use extended fractionation schemes (>10 fractions) for palliation of bone metastases (2017)

●ASTRO: Evidence-based guideline on palliative radiation therapy for bone metastases, update (2016)

Europe

●European Society for Medical Oncology (ESMO): Clinical practice guidelines on bone health in cancer (2020)

United Kingdom

●UK and Ireland Neuroendocrine Tumour Society (UKINETS): Guidance for the use of zoledronic acid/denosumab in patients with bone metastases from neuroendocrine tumours (NETs) (2019)

Australia-New Zealand

●Choosing Wisely Australia: Don't routinely use more than one fraction for palliation of non-complex bone metastases (2021)

Japan

●[In English] Japanese Society of Medical Oncology (JSMO), Japanese Orthopedic Association (JOA), Japanese Urological Association (JUA), and Japanese Society for Radiation Oncology (JASTRO): Comprehensive guideline for the diagnosis and treatment of bone metastasis (2016)

●[In Japanese] JSMO: Bone metastasis medical practice guidelines (2015)